Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04115241 · ClinicalTrials.gov registry record
Activity Levels in Bone Marrow Transplant Patients
A clinical trial of Bone Marrow Transplant, sponsored by Michael Tomasson.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04115241 is a study of Bone Marrow Transplant that is actively recruiting participants, run by Michael Tomasson. The registered enrollment target is 200 participants, above the 146-participant average among 4 other Bone Marrow Transplant trials with a reported enrollment target (37% higher). The trial reports 1 study location across 1 state.
The verdict
NCT04115241, a study of Bone Marrow Transplant, is actively recruiting participants, sponsored by Michael Tomasson.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of stay, quality of life, and hand grip strength.
Conditions Studied
Interventions
- DEVICE Actigraph
- OTHER Grip strength test
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-05-23 |
| Est. Completion | 2030-05-23 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04115241
The ClinicalTrials.gov registry entry for NCT04115241 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 146-participant average among 4 other Bone Marrow Transplant trials with a reported enrollment target (37% higher). The listed sponsor is Michael Tomasson, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Marrow Transplant appearing as the primary indexed condition, and to 2 interventions - of which Actigraph is the first listed.
NCT04115241 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT04115241 about?
NCT04115241 is a clinical study titled "Activity Levels in Bone Marrow Transplant Patients". Participants in this study will be receiving a bone marrow transplant. This study is designed to evaluate correlations between activity levels and length of stay, quality of life, and hand grip strength.
What is the current status of trial NCT04115241?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2019-05-23. Estimated completion is 2030-05-23.
What conditions does trial NCT04115241 study?
This clinical trial studies the following conditions: Bone Marrow Transplant.
What interventions are being tested in trial NCT04115241?
The interventions under investigation include: Actigraph (DEVICE), Grip strength test (OTHER).
Who is sponsoring clinical trial NCT04115241?
This trial is sponsored by Michael Tomasson, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04115241 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Marrow Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Shingrix In Recipients of Allogeneic Transplants
RECRUITING · Phase 2
-
Mosaic Trial for Stem Cell Transplant Recipients
RECRUITING · NA
-
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
ACTIVE NOT RECRUITING · Phase 2
-
Study of Iomab-B vs. Conventional Care in Older Subjects With Active, Relapsed or Refractory Acute Myeloid Leukemia
ACTIVE NOT RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.